STAT2 and neoplasm: Accordingly, we observed a significant increase in STAT1 and STAT2 signaling in survivin-specific T cells upon coculture with CCR9lo MCF7 cells, suggesting that anti-tumor type-1 immune response is impeded by tumor-specific CCR9 (Fig5D and E).